Error loading player: No playable sources found

Player size: small large

Lipid Dysregulation in Inflammation, NASH, and Cancer

Date

March 22, 2021

Speaker

Daniel A. Heller, PhD

Memorial Sloan Kettering Cancer Center

Tracks

[Joint Session] Non-Alcoholic Fatty Liver Disease, Liver Inflammation and Fibrogenesis in the Pathogenesis of Hepatobiliary Cancers

Related Products

Thumbnail for Coffee Break

Thumbnail for Short Talk: The α1-Na/K-ATPase/Src-p/PI3K Pathway Modulates the Survivin-SMAC Apoptotic “Switch” in NASH Related Hepatocellular Carcinoma: A Translational Study

Short Talk: The α1-Na/K-ATPase/Src-p/PI3K Pathway Modulates the Survivin-SMAC Apoptotic “Switch” in NASH Related Hepatocellular Carcinoma: A Translational Study

Thumbnail for A TGF-ß-ALDH2 Axis in Obesity, Metabolic Syndrome, and HCC

A TGF-ß-ALDH2 Axis in Obesity, Metabolic Syndrome, and HCC

Thumbnail for [Joint Session] Non-Alcoholic Fatty Liver Disease, Liver Inflammation and Fibrogenesis in the Pathogenesis of Hepatobiliary Cancers

[Joint Session] Non-Alcoholic Fatty Liver Disease, Liver Inflammation and Fibrogenesis in the Pathogenesis of Hepatobiliary Cancers

Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.